Effects of Antibiotics on Gut Microbiota
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The gut microbiota influences essential human functions including digestion, energy metabolism, and inflammation by modulating multiple endocrine, neural, and immune pathways of the host. Its composition and complexity varies markedly across individuals and across different sites of the gut, but provides a certain level of resilience against external perturbation. Short-term antibiotic treatment is able to shift the gut microbiota to long-term alternative dysbiotic states, which may promote the development and aggravation of disease. Common features of post-antibiotic dysbiosis include a loss of taxonomic and functional diversity combined with reduced colonization resistance against invading pathogens, which harbors the danger of antimicrobial resistance. This review summarizes the antibiotic-related changes of the gut microbiota and potential consequences in health and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics (ATB) alter gut microbiota diversity and composition leading to dysbiosis, which may affect effectiveness of ICI.”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
In the citing paper
“16S ribosomal RNA sequencing of gene amplicons of patients' feces revealed that microbiota returns to its baseline within 1-3 months after ATB discontinuation.”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
In the citing paper
“However, some bacteria may take years to fully recover [14,20].”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Cited by
Items 101–200 of 636
Claudio-Catalán, M. Á., Pharande, S. G., Quezada-Soto, A., Kishore, K. G., Rentería‐Gómez, Á., Padilla‐Vaca, F., & Gámez‐Montaño, R. (2018) · ACS Omega · doi:10.1021/acsomega.8b00170 · Cited by 54
Kelly, S. A., Nzakizwanayo, J., Rodgers, A. M., Zhao, L. M., Weiser, R., Tekko, I. A., McCarthy, H. O., Ingram, R. J., Jones, B. V., Donnelly, R. F., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00081 · Cited by 53
“The effect of antibiotic therapy on the gut microbiome is a well studied phenomenon 19 .”
Lentinan improves intestinal inflammation and gut dysbiosis in antibiotics-induced mice
Ji, X., Su, L., Zhang, P., Yue, Q., Zhao, C., Sun, X., Li, K., Liu, X., Zhang, S., & Zhao, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-23469-2 · Cited by 54
Baldanzi, G., Larsson, A. H., Sayols-Baixeras, S., Dekkers, K. F., Hammar, U., Nguyen, D., Graells, T., Ahmad, S., Volpiano, C. G., Méric, G., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04284-y · Cited by 58
Wishart, K. (2017) · Vitamins & Minerals · doi:10.4172/2376-1318.1000166 · Cited by 62
“Antibiotics have a negative effect on the gut microflora [82,83], which may be ameliorated by the use of probiotics [84,85].”
BackgroundYu, Z., & Guo, J. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128840 · Cited by 57
UEDA, K., YONEKURA, S., OGASAWARA, N., MATSUNAGA, Y., HOSHINO, R., KUROSE, H., CHIKUI, K., UEMURA, K., NAKIRI, M., NISHIHARA, K., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13836 · Cited by 48
Verdier, C., Denis, S., Gasc, C., Boucinha, L., Uriot, O., Delmas, D., Dore, J. M., Camus, C. L., Schwintner, C., & Blanquet‐Diot, S. (2021) · Microorganisms · doi:10.3390/microorganisms9020358 · Cited by 51
Ferreira, A. S., Borgonovi, T. F., de Salis, L. V. V., Leite, A. Z., Dantas, A. S., Salis, G. V. V. D., Cruz, G. N. F., de Oliveira, L. F. V., Gomes, E., Penna, A. L. B., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610189 · Cited by 51
Potential Application of Living Microorganisms in the Detoxification of Heavy Metals
Chen, R., Tu, H., & Chen, T. (2022) · Foods · doi:10.3390/foods11131905 · Cited by 53
Treatment of Drug-Induced Liver Injury
Teschke, R. (2022) · Biomedicines · doi:10.3390/biomedicines11010015 · Cited by 53
“Putting these two lines of data together [62,65,84,85], it was postulated that changes of intestinal bacteria by antibiotics may produce not-yet-identified toxins, but diagnostic parameters such as serum endotoxins were not mentioned [84].”
BackgroundLocation-Specific Oral Microbiome Possesses Features Associated With CKD
Hu, J., Iragavarapu, S., Nadkarni, G. N., Huang, R., Erazo, M., Bao, X., Verghese, D. A., Coca, S. G., Ahmed, M. K., & Peter, I. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.08.018 · Cited by 56
Li, Y., Xu, Y., Pan, C., Ren, Z., & Yang, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.005 · Cited by 48
Guardia-Escote, L., Basaure, P., Biosca-Brull, J., Cabré, M., Blanco, J., Pérez-Fernández, C., Sánchez-Santed, F., Domingo, J. L., & Colomina, M. T. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110872 · Cited by 52
Szőke, H., Kovács, Z., Bókkon, I., Vagedes, J., Erdöfi-Szabó, A., Hegyi, G., Sterner, M.-G., Kiss, Á., & Kapócs, G. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0095 · Cited by 49
Effects of Antibiotics on the Intestinal Microbiota of Mice
Hertz, F. B., Budding, A. E., van der Lugt-Degen, M., Savelkoul, P. H. M., Løbner‐Olesen, A., & Frimodt‐Møller, N. (2020) · Antibiotics · doi:10.3390/antibiotics9040191 · Cited by 44
“difficile also belong to Firmicutes, our results demonstrate a potential high risk for collateral damage during antibiotic treatment, which could have a severe consequence for patients receiving clindamycin treatment [8].”
BackgroundMethodPhage-based target discovery and its exploitation towards novel antibacterial molecules
Wan, X., Hendrix, H., Skurnik, M., & Lavigne, R. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.08.015 · Cited by 44
Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
Bosch, S., Berkhout, D. J. C., Larbi, I. B., de Meij, T. G. J., & de Boer, N. K. H. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2821-3 · Cited by 44
Stavroulaki, E. M., Suchodolski, J. S., Pilla, R., Fosgate, G. T., Sung, C., Lidbury, J. A., Steiner, J. M., & Xenoulis, P. G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253031 · Cited by 47
“The family Enterobacteriaceae is the most common microbial member that increases in abundance after antibiotic treatment in humans regardless of the antibiotic class [89].”
BackgroundEffects of antimicrobials on the gastrointestinal microbiota of dogs and cats
Stavroulaki, E. M., Suchodolski, J. S., & Xenoulis, P. G. (2022) · The Veterinary Journal · doi:10.1016/j.tvjl.2022.105929 · Cited by 46
Rosa, C. P., Brancaglion, G. A., Miyauchi-Tavares, T. M., Corsetti, P. P., & de Almeida, L. A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.06.030 · Cited by 44
Lu, F. L., Liu, F., Zhou, Q., Hu, X., & Zhang, Y. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1141 · Cited by 44
“Even with short-term administration of antibiotics may shift the microbiota to a long-term state of dysbiosis (Lange et al., 2016).”
BackgroundResultGastrointestinal Microbiome – What We Need to Know in Clinical Practice
Ortigão, R., Pimentel‐Nunes, P., Dinis-Ribeiro, M. J., & Libânio, D. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000505036 · Cited by 46
Piccioni, A., Franza, L., Brigida, M., Zanza, C., Torelli, E., Petrucci, M., Nicolò, R., Covino, M., Candelli, M., Saviano, A., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040298 · Cited by 43
“Ozone, for instance, also seems to have a similar capacity to reduce inflammation in the gut, also through microbiota modulation [31,32].”
BackgroundRen, D., Li, S.-S., Lin, H., Xia, Y., Li, Z.-M., Bo, P., Mu, R., Zhao, L., & Sun, Y. (2022) · Journal of Immunology Research · doi:10.1155/2022/4126273 · Cited by 43
“AAD is a main side reaction during antibiotic treatment and is related to inflammation, gut microbiota, and intestinal structural changes [29, 30].”
Mulder, M., Radjabzadeh, D., Hassing, R., Heeringa, J., Uitterlinden, A. G., Kraaij, R., Stricker, B. H. C., & Verbon, A. (2019) · BMC Microbiology · doi:10.1186/s12866-018-1379-1 · Cited by 44
Bosch, S., Lemmen, J., de Menezes, R. X., van der Hulst, R. W. M., Kuijvenhoven, J. P., Stokkers, P. C. F., de Meij, T. G. J., & de Boer, N. K. H. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/ab2775 · Cited by 43
Zhang, Y., Liu, Q., Yu, Y., Wang, M., Wen, C., & He, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00628 · Cited by 40
Association between antibiotics and dementia risk: A retrospective cohort study
Kim, M., Park, S. J., Choi, S., Chang, J., Kim, S. M., Jeong, S., Park, Y. J., Lee, G., Son, J. S., Ahn, J. C., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.888333 · Cited by 39
“Antibiotic exposure leads to short- and/or long-term changes in the gut microbiota such as reduced colonization resistance against pathogens, loss of diversity (Lange et al., 2016; Angelucci et al., 2019), and changes in brain chemistry (Bienenstock et al.”
BackgroundMetal-Based Nanoparticles: A Prospective Strategy for Helicobacter pylori Treatment
Yin, X., Lai, Y., Du, Y., Zhang, T., Gao, J., & Li, Z. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s405052 · Cited by 39
“In addition, the extensive use of antibiotics has had an irreversible effect on the intestinal microecology of patients.(37,40) Therefore, to eradicate H.”
BackgroundHansen, K. C. M., Ferløv-Schwensen, S. A., Henriksen, D. P., Justesen, U. S., & Sydenham, T. V. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.04.013 · Cited by 39
The association between antibiotics in the first year of life and child growth trajectory
Dawson-Hahn, E. E., & Rhee, K. E. (2019) · BMC Pediatrics · doi:10.1186/s12887-018-1363-9 · Cited by 42
Diet and microbiota-gut-brain axis in relation to tail biting in pigs: A review
Kobek‐Kjeldager, C., Schönherz, A. A., Canibe, N., & Pedersen, L. J. (2021) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2021.105514 · Cited by 44
Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review
Martín-del-Campo, F., Avesani, C. M., Stenvinkel, P., Lindholm, B., Cueto-Manzano, A. M., & Cortés–Sanabria, L. (2023) · Journal of Nephrology · doi:10.1007/s40620-022-01560-1 · Cited by 39
“Of importance, CKD patients have a high pill burden due to multiple comorbidities [21], and chronic use of some of the commonly used medications in CKD may alter the gut microbiota: (a) phosphate binders affect the intestinal environment, increasing gastrointestinal symptoms, and may bind to harmful molecules—other th…”
BackgroundChen, M., Li, D., Meng, X., Sun, Y., Liu, R., & Sun, T. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128565 · Cited by 42
IUPHAR review: Microbiota-gut-brain axis and its role in neuropsychiatric disorders
Lee, S.-H., Han, C., & Shin, C. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107749 · Cited by 42
Zhu, Z., Huang, Y., Luo, X. L., Wu, Q., He, J., Li, S., & Barba, F. J. (2019) · Food Research International · doi:10.1016/j.foodres.2019.05.003 · Cited by 38
Microbial-driven genetic variation in holobionts
Zilber‐Rosenberg, I., & ROSENBERG, E. B. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab022 · Cited by 40
Colonization resistance against multi-drug-resistant bacteria: a narrative review
Guern, R. L., Stabler, S., Gosset, P., Pichavant, M., Grandjean, T., Faure, E., Karaca, Y., Faure, K., Kipnis, É., & Dessein, R. (2021) · Journal of Hospital Infection · doi:10.1016/j.jhin.2021.09.001 · Cited by 43
Wu, J., Qiu, M., Zhang, C., Zhang, C., Wang, N., Zhao, F., Liqiao, L. V., Li, J., Lyu-Bu, A. G. A., Wang, T., et al. (2021) · Food & Function · doi:10.1039/d1fo02208c · Cited by 39
Gyawali, I., Zeng, Y., Zhou, J., Li, J., Wu, T., Shu, G., Jiang, Q., & Zhu, C. (2022) · Poultry Science · doi:10.1016/j.psj.2022.101912 · Cited by 43
Li, X., Yang, B., Shi, C., Wang, H., Yu, R., Li, Q., & Liu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859975 · Cited by 44
“Previous studies have reported that salinity stress and pathogen exposure can cause changes in intestinal microbiota composition of various aquatic organisms (28, 68–70), while the occurrence of many diseases is associated with changes in intestinal microbial composition (71).”
BackgroundOlteanu, G., Pană, M.-A., Busnatu, Ș., Lupuliasa, D., Neacșu, S. M., Mititelu, M., Musuc, A. M., Ioniță-Mîndrican, C.-B., & Boroghină, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105561 · Cited by 39
“Treatment with antibiotics causes the decrease in some groups of beneficial microorganisms, causing the important change in metabolism, the increase in intestinal sensitivity to colonization and stimulates the development of bacterial resistance to the antibiotic [126].”
BackgroundPARAGEN 1.0: A Standardized Synthetic Gene Library for Fast Cell-Free Bacteriocin Synthesis
Gabant, P., & Borrero, J. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00213 · Cited by 36
“the human commensal microbiota which has major roles in the host’s health (Blaser, 2011; Willing et al., 2011; Lange et al., 2016).”
BackgroundThe gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy
Yuan, S., Wang, K.-S., Meng, H., Hou, X.-T., Xue, J.-C., Liu, B., Cheng, W., Li, J., Zhang, H., Nan, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114893 · Cited by 37
The CF gastrointestinal microbiome: Structure and clinical impact
Rogers, G. B., Narkewicz, M. R., & Hoffman, L. R. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23544 · Cited by 37
“Often, antibiotic-induced dysbiosis is characterized by reductions in the phyla Firmicutes and Bacteroides, with compensatory expansion in the family Enterobacteriaceae; each of these changes has been associated with GI dysfunction.(48) Moreover, the detrimental effects of antibiotics can extend beyond the GI microbio…”
BackgroundBie, N., Duan, S., Meng, M., Guo, M., & Wang, C. (2021) · Food & Function · doi:10.1039/d0fo03465g · Cited by 35
Antibiotic use and colorectal neoplasia: a systematic review and meta-analysis
Aneke-Nash, C. S., Yoon, G. H., Du, M., & Liang, P. S. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000601 · Cited by 36
Mgbodile, F. C., & Nwagu, T. N. (2023) · Biotechnology Reports · doi:10.1016/j.btre.2023.e00795 · Cited by 36
“Dysbiosis can further be escalated by antivirals and antibiotics often administered during COVID-19 treatment due to alteration of the gut microbiota [38,39].”
Walusimbi, B., Lawson, M. A., Nassuuna, J., Kateete, D. P., Webb, E. L., Grencis, R. K., & Elliott, A. M. (2023) · Frontiers in Microbiomes · doi:10.3389/frmbi.2023.1174034 · Cited by 37
“Frontiers in Microbiomes 10 and may facilitate colonization by a particular species over others (Lange et al., 2016).”
BackgroundInfluence of Microbiome and Antibiotics on the Efficacy of Immune Checkpoint Inhibitors
Patel, P., Poudel, A., Kafle, S., Magar, M. T., & Cancarevic, I. (2021) · Cureus · doi:10.7759/cureus.16829 · Cited by 39
“These changes are named gut dysbiosis [25].”
BackgroundChen, J., Sun, D., Cui, H., Rao, C., Li, L., Guo, S., Yang, S., Zhang, Y., & Cao, X. (2021) · Environmental Science Nano · doi:10.1039/d1en00651g · Cited by 37
Lederer, A., Chikhladze, S., Kohnert, E., Huber, R., & Müller, A. (2021) · Diagnostics · doi:10.3390/diagnostics11112099 · Cited by 35
“Both induce a change in the gut microbiota composition and gut immunity making it impossible to see the sole effect of surgery on gut microbiota [13,38].”
BackgroundZhao, R., Qiu, Z., Bai, X., Lu, X., Qiao, Y., & Lu, X. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.10.022 · Cited by 33
Lu, J., Jin, X., Yang, S., Li, Y., Wang, X., & Wu, M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1034537 · Cited by 34
“In the treatment of Crohn’s disease, the appropriate use of antibiotics reduces bacterial load, improves intestinal microecological disorders, and reduces abdominal pain, diarrhea, and other symptoms to a certain extent, however, this is limited to short-term treatment, and long-term use may contribute to disease prog…”
BackgroundIdentification of a strong and specific antichlamydial N-acylhydrazone
Zhang, H., Kunadia, A., Lin, Y., Fondell, J. D., Seidel, D., & Fan, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185783 · Cited by 37
The prophylactic effects of BIFICO on the antibiotic-induced gut dysbiosis and gut microbiota
Wu, J., Gan, T., Zhang, Y., Xia, G., Deng, S., Lv, X., Zhang, B., & Lv, B. (2020) · Gut Pathogens · doi:10.1186/s13099-020-00379-0 · Cited by 32
The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines
Cianci, R., Franza, L., Massaro, M. G., Borriello, R., Vito, F., & Gambassi, G. (2020) · Vaccines · doi:10.3390/vaccines8040636 · Cited by 32
“Drugs in general affect the composition of the microbiota: antibiotics are the most obvious culprits and even short courses of antibiotic therapy can alter significantly the GM, promoting and aggravating diseases [92,93].”
BackgroundMaity, C., & Gupta, A. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07993 · Cited by 36
“The use of antibiotics systematically inducts a multimodal disturbances of the microbial ecology through the longitudinal decrease in the distribution, diversity and richness of autochthonous microorganisms in the gastrointestinal tract [4, 5].”
BackgroundInfluence of the gut microbiome on inflammatory and immune response after stroke
Huang, Q., & Xia, J. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05603-6 · Cited by 34
Vakili, K. G., Fathi, M., Yaghoobpoor, S., Sayehmiri, F., Nazerian, Y., Nazerian, A., Mohamadkhani, A., Khodabakhsh, P., Réus, G. Z., Hajibeygi, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.983089 · Cited by 32
“Of these medications, antibiotics have the most robust effect on the gut microbiota (Lange et al., 2016).”
BackgroundThe interaction between gut microbiome and bone health
Inchingolo, F., Inchingolo, A. M., Piras, F., Ferrante, L., Mancini, A., Palermo, A., Inchingolo, A. D., & Dipalma, G. (2024) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000863 · Cited by 36
Peng, M., Wang, Z., Peng, S., Zhang, M., Duan, Y., Li, F., Shi, S., Yang, Q., & Zhang, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223002 · Cited by 33
Rise of the guardians: Gut microbial maneuvers in bacterial infections
Gupta, U., & Dey, P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121993 · Cited by 33
The impact of liposomal linolenic acid on gastrointestinal microbiota in mice
Li, X.-X., Shi, S., Rong, L., Feng, M., & Zhong, L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s151825 · Cited by 31
“8,9,26 From either the α or β diversity analysis, the composition of both the gut and gastric microbiota in the triple therapy group presented substantial shifts at various levels after the administration compared to the rest of the groups.”
Jia, J., Zheng, W., Zhang, C., Zhang, P., Guo, X., Song, S., & Ai, C. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.144 · Cited by 31
Beucher, G., Charlier, C., & Cazanave, C. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.10.022 · Cited by 39
Han, Z., Sun, J., Jiang, B., Chen, K., Ge, L., Sun, Z., & Wang, A. (2024) · Communications Biology · doi:10.1038/s42003-024-06727-z · Cited by 30
“Antibioticscanperturbthemicrobiotacompositionandcausegutdysbiosis, buttheireffectscanbemorecomplex 32,33 .”
Marascio, N., Scarlata, G. G. M., Romeo, F., Cicino, C., Trecarichi, E. M., Quirino, A., Torti, C., Matera, G., & Russo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119307 · Cited by 32
Collinet, A., Grimm, P., Julliand, S., & Julliand, V. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.646294 · Cited by 32
“The authors concluded that systemic innate immune defenses could be affected during an antibiotic challenge in response to microbiota disruption (Lankelma et al., 2016).”
BackgroundMaternal peripartum antibiotic exposure and the risk of postpartum depression
Murphy, J. R., Paul, S., Dunlop, A. L., & Corwin, E. J. (2018) · Research in Nursing & Health · doi:10.1002/nur.21881 · Cited by 30
Sanyaolu, L. N., Oakley, N. J., Nurmatov, U. B., Dolwani, S., & Ahmed, H. (2020) · Colorectal Disease · doi:10.1111/codi.14921 · Cited by 31
Li, Y., Zhu, Y., Wei, H., Chen, Y., & Shang, H. (2020) · Current Microbiology · doi:10.1007/s00284-020-02240-8 · Cited by 31
Drug–Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics
Mohamed, A. A., Menon, H., Chulkina, M., Yee, N. S., & Pinchuk, I. V. (2021) · Biomedicines · doi:10.3390/biomedicines9030259 · Cited by 27
“against invading pathogenic an oppo tunistic microorga isms [37].”
BackgroundAmedei, A., Capasso, C., Nannini, G., & Supuran, C. T. (2021) · Mediators of Inflammation · doi:10.1155/2021/6926082 · Cited by 29
“Antibiotics are a strong weapon against pathogenic bacteria but can also damage commensal organisms, leading to the loss of microbial diversity and reduced colonization resistance against pathogens [65].”
Knisely, A. T., Seo, Y. D., Wargo, J. A., & Chelvanambi, M. (2023) · Cancers · doi:10.3390/cancers15030777 · Cited by 32
“Antibiotic use among cancer patients has increased over time and while this may contribute to decreased mortality from an infection standpoint, antibiotic use can impart rapid and long-lasting effects on gut microbiota composition, leading to decreased alpha diversity, metabolic capacity changes, loss of vital taxa, a…”
BackgroundLi, X., Zhu, R., Liu, Q., Sun, H., Sheng, H., & Zhu, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136691 · Cited by 36
Antonelli, M. M., Martín‐Loeches, I., Dimοpoulos, G., Gasbarrini, A., & Vallecoccia, M. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05873-x · Cited by 30
Gontjes, K. J., Gibson, K. E., Lansing, B. J., Mantey, J., Jones, K. M., Cassone, M., Wang, J., Mills, J. P., Mody, L., & Patel, P. K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.44959 · Cited by 26
Sen, G., Öztaş, N. Ş., Değerli, E., Can, G., Turna, H., & Özgüroğlu, M. (2023) · Lung Cancer · doi:10.1016/j.lungcan.2023.107347 · Cited by 27
“ATB treatment, even in the short term, causes a loss of microbial diversity called dysbiosis, and this dysbiosis can persist for up to several months after the ATB therapy [11,12].”
Antibiotics and steroids, the double enemies of anticancer immunotherapy: a review of the literature
Meriggi, F. A., & Zaniboni, A. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02786-3 · Cited by 30
Antimicrobial therapy during cancer treatment: Beyond antibacterial effects
Ghanem, S., Kim, C. J., Dutta, D., Salifu, M. O., & Lim, S. H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13238 · Cited by 27
Zhan, M., Yang, X., Zhao, C., Han, Y., Xie, P., Mo, Z., Xiao, J., Cao, Y., Xiao, H., & Song, M. (2024) · Food & Function · doi:10.1039/d3fo04378a · Cited by 26
Li, G., Zhang, T., Yang, W.-G., Zhong, H.-L., Xiao, P., Liu, L., Wang, Y., Chen, H., Kong, R., Wang, G., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00329-4 · Cited by 27
Global meta‐analysis reveals the drivers of gut microbiome variation across vertebrates
Xie, Y., Xu, S., Xi, Y., Li, Z., Zuo, E., Xing, K., Bai, L., & Li, K. (2024) · iMetaOmics. · doi:10.1002/imo2.35 · Cited by 26
“At the same time, other factors such as antibiotic exposure and gastrointestinal dysfunction can also lead to changes in the gut microbiota of vertebrates [28, 29].”
Vancomycin-induced gut dysbiosis duringPseudomonas aeruginosapulmonary infection in a mice model
Rosa, C. P., Pereira, J. A., Santos, N. C. D. M., Brancaglion, G. A., Silva, E. N., Tagliati, C. A., Novaes, R. D., Corsetti, P. P., & de Almeida, L. A. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ab0919-432r · Cited by 27
Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021?
Hawryłkowicz, V., Lietz–Kijak, D., Kaźmierczak-Siedlecka, K., Sołek-Pastuszka, J., Stachowska, L., Folwarski, M., Parczewski, M., & Stachowska, E. (2021) · Nutrients · doi:10.3390/nu13103385 · Cited by 26
“Short-term modifications of eating habits have a negligible effect on bacterial composition, unlike antibiotic treatments, the impact of which is powerful, resulting in loss of taxonomic diversity and increased counts of potentially pathogenic bacteria [92].”
BackgroundHarnessing Gut Microbiota for Biomimetic Innovations in Health and Biotechnology
Beltrán-Velasco, A. I., & Clemente‐Suárez, V. J. (2025) · Biomimetics · doi:10.3390/biomimetics10020073 · Cited by 33
Liu, S., He, L., Jiang, Q., Duraipandiyan, V., Al-Dhabi, N. A., Liu, G., Kang, Y., & Yin, Y. (2018) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.9131 · Cited by 26
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies
Gobbo, M. M., Bomfim, M. B., Alves, W. Y., Oliveira, K. C., Corsetti, P. P., & de Almeida, L. A. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103140 · Cited by 26
Impacts of polystyrene nanoplastics on zebrafish gut microbiota and mechanistic insights
Rehman, A., Habumugisha, T., Huang, F.-Y., Zhang, Z., Kiki, C., Al, M. A., Yan, C., Shaheen, U., & Zhang, X. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118332 · Cited by 25
Nyberg, O., Rico, A., Guinée, J. B., & Henriksson, P. J. G. (2021) · The International Journal of Life Cycle Assessment · doi:10.1007/s11367-021-01908-y · Cited by 26
“Additionally, negative effects to humans include: (c) indiscriminately killing both pathogenic and non-pathogenic bacteria, including bacterial communities that fill useful biological functions (Jernberg et al. 2010; Lange et al. 2016); (d) induce side effects in humans (Wypych and Marsland 2018); and (e) promote the…”
BackgroundAhmed, L. A., & Al‐Massri, K. F. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220222105004 · Cited by 26
von Itzstein, M. S., Gonugunta, A. S., Sheffield, T. Y., Homsi, J., Dowell, J. E., Koh, A. Y., Raj, P., Fattah, F. J., Wang, Y., Basava, V. S., et al. (2022) · Cancers · doi:10.3390/cancers14051327 · Cited by 24
“The detrimental effect of antibiotics is primarily thought to arise from changes to the gut microbiome, which plays a key role in immune function regulation and has been found to influence ICI response [28,29].”
BackgroundKumar, A., Al-Hassi, H. O., Steed, H., Phipps, O., & Brookes, M. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/8416578 · Cited by 24
“'ere are multiple studies that implicate antibiotic use as a risk factor in the pathogenesis of CD by altering the microbial composition [99, 101, 102].”
BackgroundZhang, H., Xu, Z., Chen, W., Huang, F., Chen, S., Wang, X., & Yang, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1081717 · Cited by 26
“Short-term antibiotic therapy can convert the intestinal flora to a long-term dysbiotic state, which may promote the development and progression of the disease (6).”
BackgroundMünch, P. C., Eberl, C., Woelfel, S., Ring, D., Fritz, A., Herp, S., Lade, I., Geffers, R., Franzosa, E. A., Huttenhower, C., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.05.013 · Cited by 25
Grim, K. P., Radin, J. N., Solórzano, P. K. P., Morey, J. R., Frye, K. A., Ganio, K., Neville, S. L., McDevitt, C. A., & Kehl‐Fie, T. E. (2020) · Journal of Bacteriology · doi:10.1128/jb.00014-20 · Cited by 24
“Thus, not only does zincophore efflux represent a potential therapeutic target but one that may minimize the detrimental impact that broadspectrum antibiotics have on the host’s microbiota (75, 76).”
BackgroundGut microbiota and sepsis and sepsis-related death: a Mendelian randomization investigation
Shang, W., Zhang, S., Qian, H., Huang, S., Li, H., Liu, J., & Chen, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1266230 · Cited by 23
“Gut microbiota is the collection of all microorganisms that colonize the gastrointestinal system and in fl uence basic body functions such as digestion, energetic metabolism, and immune response (4).”
BackgroundBlount, K., Jones, C. R., Walsh, D. M., Gonzalez, C., & Shannon, W. D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.781275 · Cited by 24
“Group relative abundances (π) with confidence limits were generated by fitting a Dirichlet-multinomial (DM) distribution to OTU data using maximum likelihood estimation (La Rosa et al., 2012).”
BackgroundMethod
Metadata
- Authors
- Lange, K., Buerger, M., Stallmach, A., & Bruns, T.
- Affiliations
- Jena University Hospital (DE)
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 34
- Issue
- 3
- Pages
- 260-268
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2320251182
- Cited by
- 607
- References
- 101
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 92 · 2023: 96 · 2022: 99 · 2021: 79 · 2020: 48 · 2019: 46 · 2018: 33 · 2017: 19 · 2016: 7
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- antibiotics, gut microbiota, dysbiosis, colonization resistance, antimicrobial resistance, microbial diversity, host-microbe interactions, energy metabolism, inflammation, disease susceptibility
- MeSH terms
- Gastrointestinal Microbiome, Anti-Bacterial Agents, Humans, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.